Researcher
Guido Vanham
Affiliations
- Virology (Research unit)
Member
From1 Jan 1989 → 30 Jul 2019
Projects
11 - 19 of 19
- Genotypic and phenotypic characterization of recently sexually transmitted HIVFrom1 Jan 2011 → 31 Dec 2014
- Development of combined highly active anti-retroviral microbicides and or biomakers to assess safety of microbicidesFrom1 Jul 2010 → 19 Nov 2018
- Promoting HTLV-1 blood transfusion safety in an endemic country. Towards expanded, evidence-based HTLV-1 control strategies of Peruvian Blood BanksFrom1 Mar 2010 → 31 Dec 2020
- Combined Highly Active Anti-Retroviral MicrobicidesFrom1 Jan 2010 → 30 Jun 2015
- In vivo mRNA delivery into dendritic cells for immunotherapyFrom1 Jan 2010 → 31 Dec 2015
- Novel immmunization strategy, using non-viral carriers for mRNA, encoding HIV protein variants.From1 Jul 2009 → 31 Aug 2013
- Next generation HIV-1 immunogens inducing broadly reactive neutralising antibodiesFrom1 Feb 2008 → 31 Jul 2012
- Inhibition of human immunodeficiency virus (HIV) replicationFrom1 Jan 2007 → 31 Mar 2012
- European Microbicides ProjectFrom1 Jan 2004 → 31 Dec 2009
Publications
1 - 10 of 206
- Diagnosing viral infections through T-cell receptor sequencing of activated CD8+ T cells(2024)
Authors: Alexandra Vujkovic, My Hà, Tessa de Block, Lida van Petersen, Isabel Brosius, Caroline Theunissen, SH van Ierssel, Esther Bartholomeus, Wim Adriaensen, Guido Vanham, et al.
Pages: 507-516 - Leveraging T-cell receptor - epitope recognition models to disentangle unique and cross-reactive T-cell response to SARS-CoV-2 during COVID-19 progression/resolution(2023)
Authors: Anna Postovskaya, Alexandra Vujkovic, Tessa De Block, Lida van Petersen, Maartje van Frankenhuijsen, Isabel Brosius, E Bottieau, Christophe Van Dijck, Caroline Theunissen, Sabrina H van Ierssel, et al.
- Efficient induction of antigen-specific CD8(+) T-cell responses by cationic peptide-based mRNA nanoparticles(2022)
Authors: Sigrid D'haese, Thessa Laeremans, Sabine den Roover, Sabine D. Allard, G Vanham, Joeri L. Aerts
- Qualitative plasma viral load determination as a tool for screening of viral reservoir size in PWH(2022)
Authors: Thessa Laeremans, Sigrid D'haese, Jonathan Aernout, Kurt Barbé, Pieter Pannus, Sofie Rutsaert, Ellen Vancutsem, Guido Vanham, Coca Necsoi, Ward De Spiegelaere, et al.
Pages: 1761-1768 - Closing schools for SARS-CoV-2: a pragmatic rapid recommendation(2021)
Authors: Geertruida Bekkering, Nicolas Delvaux, Patrik Vankrunkelsven, Jaan Toelen, Sigrid Aertgeerts, Sofie Crommen, Pedro De Bruyckere, Ignaas Devisch, Tinne Lernout, Katrien Masschalck, et al.
- CD32(+)CD4(+) memory T cells are enriched for total HIV-1 DNA in tissues from humanized mice(2021)
Authors: Philipp Alexander Adams, Virginie Fievez, Rafaela Schober, Mathieu Amand, Gilles Iserentant, Sofie Rutsaert, Geraldine Dessilly, G Vanham, Fanny Hedin, Antonio Cosma, et al.
- Cytotoxic CD8+T cells expressing CXCR5 are detectable in HIV-1 elite controllers after prolonged in vitro peptide stimulation(2021)
Authors: Philipp Alexander Adams, Gilles Iserentant, Jean-Yves Servais, Linos Vandekerckhove, G Vanham, Carole Seguin-Devaux
- Essentials in saline pharmacology for nasal or respiratory hygiene in times of COVID-19(2021)
Authors: Huijghebaert Suzy, Hoste Levi, Guido Vanham
Pages: 1275-1293 - COVID-19: does the infectious inoculum dose-response relationship contribute to understanding heterogeneity in disease severity and transmission dynamics?(2021)
Authors: W Van Damme, Ritwik Dahake, Remco van de Pas, Guido Vanham, Yibeltal Assefa
- Off the beaten path: novel mRNA-nanoformulations for therapeutic vaccination against HIV(2021)
Authors: Sigrid D'haese, Celine Lacroix, Felipe Garcia, Montserrat Plana, Simona Ruta, G Vanham, Bernard Verrier, Joeri L. Aerts
Pages: 1016-1033